21 – 30 of 37
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Dietary folate intake and pancreatic cancer risk : Results from the European prospective investigation into cancer and nutrition
(
- Contribution to journal › Article
-
Mark
Socioeconomic Effect of Education on Pancreatic Cancer Risk in Western Europe : An Update on the EPIC Cohorts Study
2019) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 28(6). p.1089-1092(
- Contribution to journal › Article
-
Mark
Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
Circulating insulin-like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition
(
- Contribution to journal › Article
-
Mark
Estimated Substitution of Tea or Coffee for Sugar-Sweetened Beverages Was Associated with Lower Type 2 Diabetes Incidence in Case-Cohort Analysis across 8 European Countries in the EPIC-InterAct Study
(
- Contribution to journal › Article
-
Mark
Coffee and tea drinking in relation to the risk of differentiated thyroid carcinoma : results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study
(
- Contribution to journal › Article
- 2018
-
Mark
Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation
(
- Contribution to journal › Article
-
Mark
Interplay between genetic predisposition, macronutrient intake and type 2 diabetes incidence : analysis within EPIC-InterAct across eight European countries
(
- Contribution to journal › Article
-
Mark
Anti-CA15.3 and Anti-CA125 Antibodies and ovarian cancer risk : Results from the EPIC cohort
(
- Contribution to journal › Article